Litvin publishes research on the effects of elexacaftor-tezacaftor-ivacaftor on those with cystic fibrosis

In March, Marina Litvin, MD and collaborators published research titled the “Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis,” in the “Journal of Cystic Fibrosis.” The study’s purpose was to bring definition to the effect that elexacaftor-tezacaftor-ivacaftor (ETI) has on body weight, body mass index (BMI), blood pressure, lipids […]